109 related articles for article (PubMed ID: 84550)
21. L-dopa metabolism in genetically hypertensive mice: effect of pargyline.
Buu NT; Duhaime J; Racz K; Kuchel O; Schlager G
Can J Physiol Pharmacol; 1987 Dec; 65(12):2390-5. PubMed ID: 3449195
[TBL] [Abstract][Full Text] [Related]
22. [Fluorimetric assay of 3-o-methyldopamine and 4-0-methyldopamine in rat urine and o-methylation of dopamine].
Bidard JN; Cronenberger L
C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(5):389-92. PubMed ID: 404066
[TBL] [Abstract][Full Text] [Related]
23. Effects of L-DOPA on the concentrations of free and sulfoconjugated catecholamines in plasma, cerebrospinal fluid, urine, and central and peripheral nervous system tissues of the rat.
Buu NT; Duhaime J; Kuchel O
J Neurochem; 1985 Mar; 44(3):787-92. PubMed ID: 3838339
[TBL] [Abstract][Full Text] [Related]
24. Cyclazocine and norepinephrine uptake, metabolism, and turnover in the rat brain.
Russi GD
J Pharm Sci; 1985 Jan; 74(1):97-9. PubMed ID: 3981430
[TBL] [Abstract][Full Text] [Related]
25. The role of 3-O-methyldopa in the side effects of L-dopa.
Lee ES; Chen H; King J; Charlton C
Neurochem Res; 2008 Mar; 33(3):401-11. PubMed ID: 17713853
[TBL] [Abstract][Full Text] [Related]
26. Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine.
Peleg D; Munsick RA; Diker D; Goldman JA; Ben-Jonathan N
J Clin Endocrinol Metab; 1986 May; 62(5):911-4. PubMed ID: 3958127
[TBL] [Abstract][Full Text] [Related]
27. The metabolism of tritiated dopamine in regions of the rat brain in vivo. II. The significance of the neutral metabolites of catecholamines.
Taylor KM; Laverty R
J Neurochem; 1969 Sep; 16(9):1367-76. PubMed ID: 5817555
[No Abstract] [Full Text] [Related]
28. Depletion of S-adenosyl-L-methionine in mouse brain by antidepressive drugs.
Taylor KM; Randall PK
J Pharmacol Exp Ther; 1975 Aug; 194(2):303-10. PubMed ID: 1151760
[TBL] [Abstract][Full Text] [Related]
29. The metabolism of tritiated dopamine in regions of the rat brain in vivo. I. The separation of catecholamines and their metabolites.
Taylor KM; Laverty R
J Neurochem; 1969 Sep; 16(9):1361-6. PubMed ID: 5808103
[No Abstract] [Full Text] [Related]
30. Decreased cerebral catabolism of [3H]histamine in vivo after S-adenosylmethionine administration.
Schatz RA; Stramentinoli G; Sellinger OZ
J Pharmacol Exp Ther; 1981 Jan; 216(1):118-24. PubMed ID: 7452498
[TBL] [Abstract][Full Text] [Related]
31. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
Liu XX; Wilson K; Charlton CG
Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
[TBL] [Abstract][Full Text] [Related]
32. Effects of hypercortisolemia or hyperinsulinemia on neurochemical indices of catecholamine release and synthesis in conscious rats.
Wolfovitz E; Pacak K; Abassi Z; Kopin IJ; Goldstein DS
J Auton Nerv Syst; 1995 Aug; 54(2):104-12. PubMed ID: 7499722
[TBL] [Abstract][Full Text] [Related]
33. A sensitive radioenzymatic assay for dopamine, norepinephrine, and epinephrine in plasma and tissue.
Ben-Jonathan N; Porter JC
Endocrinology; 1976 Jun; 98(6):1497-507. PubMed ID: 1278114
[TBL] [Abstract][Full Text] [Related]
34. Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.
Reches A; Jiang D; Fahn S
Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):34-7. PubMed ID: 7121609
[TBL] [Abstract][Full Text] [Related]
35. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
Goldberg MR; Tung CS; Feldman RD; Smith HE; Oates JA; Robertson D
J Pharmacol Exp Ther; 1982 Mar; 220(3):552-60. PubMed ID: 7062266
[TBL] [Abstract][Full Text] [Related]
36. High-performance liquid chromatographic determination, with ultraviolet detection, of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in rat tissues and simultaneously of normetanephrine and metanephrine for phenylethanolamine-N-methyltransferase or catechol-O-methyltransferase activities.
Guattari B
J Chromatogr; 1991 Jun; 567(1):254-60. PubMed ID: 1918253
[TBL] [Abstract][Full Text] [Related]
37. Increased accumulation of ( 3 H) catecholamines formed from ( 3 H) dopa after treatment with caffeine and aminophylline.
Waldeck B
J Pharm Pharmacol; 1972 Aug; 24(8):654-5. PubMed ID: 4403749
[No Abstract] [Full Text] [Related]
38. [Effect of S-adenosyl-L-homocysteine of dopamine catabolism].
Bidard JN; Sokoloff P; Cronenberger L; Pacheco H
Arch Int Physiol Biochim; 1979 May; 87(2):253-64. PubMed ID: 92923
[TBL] [Abstract][Full Text] [Related]
39. The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.
Benson R; Crowell B; Hill B; Doonquah K; Charlton C
Neurochem Res; 1993 Mar; 18(3):325-30. PubMed ID: 8479601
[TBL] [Abstract][Full Text] [Related]
40. [Effects of S-adenosyl-L-methionine on the cerebral energy metabolism and microcirculation in the rats subjected to transient forebrain ischemia].
Sato H; Tobita M; Ohtomo H; Izumiyama M; Kogure K
No To Shinkei; 1987 Dec; 39(12):1151-6. PubMed ID: 3446252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
